Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine and Cognitive Function After Surgery
NCT03025087Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jun 2017
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in Post-operative cognitive dysfunction (POCD), sponsored by Duke University. Started Jun 2017; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT03025087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025087.